Detailed Narrative
Strong Q4 and FY26 Performance
Smith & Wesson reported excellent fourth quarter and full fiscal year 2026 results, surpassing expectations across key metrics. Net sales for Q4 increased nearly 27% year over year to $178.4 million, with adjusted EBITDA up 31.7% and adjusted EPS rising 77%. For the full fiscal year, top-line revenue grew over 10%, adjusted EPS increased more than 25%, and adjusted EBITDA was up 7%, demonstrating robust financial health.
Market Share Gains Driven by Innovation
The company continued its momentum in market share growth, significantly outpacing the broader market. Handgun unit shipments into the sporting goods channel surged 23% in Q4, compared to a NICS increase of only 1.1%, while long gun shipments rose 28.7% against a 3.5% NICS increase. New products, including the M&P pistols and revitalized revolver lines, accounted for nearly 38% of shipments in both Q4 and the full fiscal year, highlighting the success of their innovation strategy.
Strategic Investment in Manufacturing Capacity
Smith & Wesson plans significant investments in its Springfield facility during fiscal 2027 to expand capacity and increase operational efficiency. This strategic capital expenditure is expected to add approximately $20 million to the usual $25 million to $30 million annual capex. The investment will include 20 new CNC machines, with half expected online by summer and the remainder by the end of the calendar year, reinforcing Springfield as the company's machining center of excellence.
Healthy Balance Sheet and Capital Allocation
The company fortified its balance sheet, generating over $114 million in cash from operations for the full fiscal year and retiring $60 million in debt. They closed FY26 with just $20 million in debt, down from $80 million at the end of FY25, resulting in a net cash position of $8.2 million. Capital allocation priorities remain focused on investing back into the business, maintaining the quarterly dividend of $0.13 per share, and opportunistically pursuing share buybacks under existing authorization.
Inventory Management and Channel Health
Smith & Wesson ended Q4 with $156 million in internal inventory, down from $190 million a year ago, reflecting effective sales and operations planning. Channel inventory remained flat in units relative to both Q3 and the prior year, signaling healthy sell-through at retail. This clean inventory position is expected to provide a strong foundation as the company enters fiscal 2027.
Product Strategy and Average Selling Prices
The company's focus on innovation and brand power has enabled it to maintain strong average selling prices (ASPs). Sequentially in Q4, handgun ASPs were up 4.3% and long gun ASPs increased 4.5%. A 2% to 3% price increase implemented in January was well-received by distributors, further demonstrating the strength of the Smith & Wesson brand and its new product introductions.